{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T03:40:19Z","timestamp":1732419619244,"version":"3.28.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,23]]},"DOI":"10.7759\/cureus.74324","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T02:40:36Z","timestamp":1732416036000},"source":"Crossref","is-referenced-by-count":0,"title":["Synergistic Effects of Anti-echinococcosis Drug Candidates Combined With Atovaquone in Culture Assays and Mice With Primary Infections of Echinococcus multilocularis"],"prefix":"10.7759","author":[{"given":"Hirokazu","family":"Kouguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohito","family":"Koyano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariaki","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinpei","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigehiro","family":"Enkai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000722","article-title":"The global burden of alveolar echinococcosis","volume":"4","author":"Torgerson PR","year":"2010","unstructured":"Torgerson PR, Keller K, Magnotta M, Ragland N. The global burden of alveolar echinococcosis. PLoS Negl Trop Dis. 2010, 4:e722. 10.1371\/journal.pntd.0000722","journal-title":"PLoS Negl Trop Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00075-18","article-title":"Echinococcosis: advances in the 21st century","volume":"32","author":"Wen H","year":"2019","unstructured":"Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, McManus DP. Echinococcosis: advances in the 21st century. Clin Microbiol Rev. 2019, 32:e00075. 10.1128\/CMR.00075-18","journal-title":"Clin Microbiol Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.38","article-title":"Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance","volume":"47","author":"Steiger U","year":"1990","unstructured":"Steiger U, Cotting J, Reichen J. Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance. Clin Pharmacol Ther. 1990, 47:347-53. 10.1038\/clpt.1990.38","journal-title":"Clin Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006422","article-title":"Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets","volume":"12","author":"Siles-Lucas M","year":"2018","unstructured":"Siles-Lucas M, Casulli A, Cirilli R, Carmena D. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets. PLoS Negl Trop Dis. 2018, 12:e0006422. 10.1371\/journal.pntd.0006422","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2018.06.004","article-title":"Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis","volume":"8","author":"Rufener R","year":"2018","unstructured":"Rufener R, Ritler D, Zielinski J, et al.. Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis. Int J Parasitol Drugs Drug Resist. 2018, 8:331-40. 10.1016\/j.ijpddr.2018.06.004","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2020.06.002","article-title":"Drug repurposing applied: activity of the anti-malarial mefloquine against Echinococcus multilocularis","volume":"13","author":"Lundstr\u00f6m-Stadelmann B","year":"2020","unstructured":"Lundstr\u00f6m-Stadelmann B, Rufener R, Hemphill A. Drug repurposing applied: activity of the anti-malarial mefloquine against Echinococcus multilocularis. Int J Parasitol Drugs Drug Resist. 2020, 13:121-9. 10.1016\/j.ijpddr.2020.06.002","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13567-019-0710-7","article-title":"In vitro and in vivo effects of 3-bromopyruvate against Echinococcus metacestodes","volume":"50","author":"Xin Q","year":"2019","unstructured":"Xin Q, Yuan M, Li H, Song X, Lu J, Jing T. In vitro and in vivo effects of 3-bromopyruvate against Echinococcus metacestodes. Vet Res. 2019, 50:96. 10.1186\/s13567-019-0710-7","journal-title":"Vet Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-021-04866-4","article-title":"In vivo and in vitro efficacy of crocin against Echinococcus multilocularis","volume":"14","author":"Liu C","year":"2021","unstructured":"Liu C, Fan H, Guan L, Ge RL, Ma L. In vivo and in vitro efficacy of crocin against Echinococcus multilocularis. Parasit Vectors. 2021, 14:364. 10.1186\/s13071-021-04866-4","journal-title":"Parasit Vectors"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-021-04618-4","article-title":"Anti-echinococcal effect of verapamil involving the regulation of the calcium\/calmodulin-dependent protein kinase II response in vitro and in a murine infection model","volume":"14","author":"Gao HJ","year":"2021","unstructured":"Gao HJ, Sun XD, Luo YP, et al.. Anti-echinococcal effect of verapamil involving the regulation of the calcium\/calmodulin-dependent protein kinase II response in vitro and in a murine infection model. Parasit Vectors. 2021, 14:108. 10.1186\/s13071-021-04618-4","journal-title":"Parasit Vectors"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2019.102004","article-title":"Mitochondrial complex III in larval stage of Echinococcus multilocularis as a potential chemotherapeutic target and in vivo efficacy of atovaquone against primary hydatid cysts","volume":"75","author":"Enkai S","year":"2020","unstructured":"Enkai S, Inaoka DK, Kouguchi H, Irie T, Yagi K, Kita K. Mitochondrial complex III in larval stage of Echinococcus multilocularis as a potential chemotherapeutic target and in vivo efficacy of atovaquone against primary hydatid cysts. Parasitol Int. 2020, 75:102004. 10.1016\/j.parint.2019.102004","journal-title":"Parasitol Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00378-07","article-title":"Anaerobic NADH-fumarate reductase system is predominant in the respiratory chain of Echinococcus multilocularis, providing a novel target for the chemotherapy of alveolar echinococcosis","volume":"52","author":"Matsumoto J","year":"2008","unstructured":"Matsumoto J, Sakamoto K, Shinjyo N, et al.. Anaerobic NADH-fumarate reductase system is predominant in the respiratory chain of Echinococcus multilocularis, providing a novel target for the chemotherapy of alveolar echinococcosis. Antimicrob Agents Chemother. 2008, 52:164-70. 10.1128\/AAC.00378-07","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-021-04230-5","article-title":"In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice","volume":"40","author":"Enkai S","year":"2021","unstructured":"Enkai S, Kouguchi H, Inaoka DK, Irie T, Yagi K, Kita K. In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice. Eur J Clin Microbiol Infect Dis. 2021, 40:1815-20. 10.1007\/s10096-021-04230-5","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2022.108707","article-title":"Data on the combined effect of atovaquone, mefloquine, and 3-bromopyruvic acid against Echinococcus multilocularis protoscoleces","volume":"45","author":"Kouguchi H","year":"2022","unstructured":"Kouguchi H, Enkai S, Matsuyama H, Hidaka M, Inaoka DK, Kita K, Yagi K. Data on the combined effect of atovaquone, mefloquine, and 3-bromopyruvic acid against Echinococcus multilocularis protoscoleces. Data Brief. 2022, 45:108707. 10.1016\/j.dib.2022.108707","journal-title":"Data Brief"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1017\/S0022149X15001169","article-title":"The timing of worm exclusion in dogs repeatedly infected with the cestode Echinococcus multilocularis","volume":"90","author":"Kouguchi H","year":"2016","unstructured":"Kouguchi H, Irie T, Matsumoto J, Nakao R, Sugano Y, Oku Y, Yagi K. The timing of worm exclusion in dogs repeatedly infected with the cestode Echinococcus multilocularis. J Helminthol. 2016, 90:766-72. 10.1017\/S0022149X15001169","journal-title":"J Helminthol"},{"key":"ref15","unstructured":"The R Project for statistical computing. (2022). Accessed. July 25, 2024:  https:\/\/www.r-project.org\/."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4894(57)90041-3","article-title":"Studies on the metabolism of Echinococcus granulosus. II. Some observations on the carbohydrate metabolism of hydatid cyst scolices","volume":"6","author":"Agosin M","year":"1957","unstructured":"Agosin M. Studies on the metabolism of Echinococcus granulosus. II. Some observations on the carbohydrate metabolism of hydatid cyst scolices. Exp Parasitol. 1957, 6:586-93. 10.1016\/0014-4894(57)90041-3","journal-title":"Exp Parasitol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1017\/s0031182000048769","article-title":"Differences in the chemical composition and carbohydrate metabolism of Echinococcus granulosus (horse and sheep strains) and E. multilocularis","volume":"77","author":"McManus DP","year":"1978","unstructured":"McManus DP, Smyth JD. Differences in the chemical composition and carbohydrate metabolism of Echinococcus granulosus (horse and sheep strains) and E. multilocularis. Parasitology. 1978, 77:103-9. 10.1017\/s0031182000048769","journal-title":"Parasitology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(01)00667-x","article-title":"Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase","volume":"173","author":"Ko YH","year":"2001","unstructured":"Ko YH, Pedersen PL, Geschwind JF. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett. 2001, 173:83-91. 10.1016\/s0304-3835(01)00667-x","journal-title":"Cancer Lett"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18632\/genesandcancer.9","article-title":"Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cells","volume":"5","author":"Zhang Q","year":"2014","unstructured":"Zhang Q, Zhang Y, Zhang P, et al.. Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cells. Genes Cancer. 2014, 5:100-12. 10.18632\/genesandcancer.9","journal-title":"Genes Cancer"},{"key":"ref20","article-title":"Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia","volume":"65","author":"Xu R","year":"2005","unstructured":"Xu R, Pelicano H, Zhou Y, et al.. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005, 65:613-21.","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/nature12031","article-title":"The genomes of four tapeworm species reveal adaptations to parasitism","volume":"496","author":"Tsai IJ","year":"2013","unstructured":"Tsai IJ, Zarowiecki M, Holroyd N, et al.. The genomes of four tapeworm species reveal adaptations to parasitism. Nature. 2013, 496:57-63. 10.1038\/nature12031","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16164","article-title":"The mitochondrial coenzyme Q junction and complex III: biochemistry and pathophysiology","volume":"289","author":"Banerjee R","year":"2022","unstructured":"Banerjee R, Purhonen J, Kallij\u00e4rvi J. The mitochondrial coenzyme Q junction and complex III: biochemistry and pathophysiology. FEBS J. 2022, 289:6936-58. 10.1111\/febs.16164","journal-title":"FEBS J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306218-synergistic-effects-of-anti-echinococcosis-drug-candidates-combined-with-atovaquone-in-culture-assays-and-mice-with-primary-infections-of-echinococcus-multilocularis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T02:40:38Z","timestamp":1732416038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306218-synergistic-effects-of-anti-echinococcosis-drug-candidates-combined-with-atovaquone-in-culture-assays-and-mice-with-primary-infections-of-echinococcus-multilocularis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.74324","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,23]]}}}